Related Experiment Video
Updated: Jun 27, 2026
16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Endocardial pacemaker implantation in neonates and infants
Indian Pacing and Electrophysiology Journal
|September 1, 2006
Summary
Transvenous pacemaker lead implantation is preferred for adults due to superior performance. In infants, endocardial pacing shows promise with low morbidity and good outcomes, despite earlier concerns.
Area of Science:
- Pediatric Cardiology
- Cardiac Electrophysiology
- Medical Device Technology
Background:
- Transvenous lead implantation is standard for adults, offering high performance and low complication rates.
- Historically, epicardial leads were used in pediatric patients, especially neonates and infants.
- Advancements in generator size and lead technology have enabled endocardial approaches in younger patients.
Discussion:
- Endocardial implantation in neonates and infants presents challenges, including potential venous occlusion and future access concerns.
- However, accumulating evidence suggests that with current low-profile leads, endocardial pacing can be achieved with minimal morbidity.
- This approach may offer a viable alternative to epicardial pacing in this population.
Key Insights:
- Endocardial pacemaker lead implantation is increasingly feasible and safe in neonates and infants.
- Low-profile leads mitigate risks associated with venous access and growth in pediatric patients.
- Outcomes for endocardial pacing in infants are comparable to traditional methods, with reduced invasiveness.
Outlook:
- Further research should focus on long-term outcomes and standardized techniques for pediatric endocardial lead implantation.
- Continued development of pediatric-specific leads and implantation tools is crucial.
- Wider adoption of endocardial pacing in infants could improve patient management and reduce healthcare costs.
